GERCOR prognostic index | |||||
---|---|---|---|---|---|
Variable | HR (95% CI) | P value | c-index | Schemper (%) | NRI (95% CI) |
GERCOR (2 vs. 1) | 1.82 [1.43 – 2.33] | <0.0001 | |||
GERCOR (3 vs. 1) | 3.10 [2.38 – 4.05] | <0.0001 | 0.63 [0.61 -0.66] *0.63 | 6.44 | |
Improvement of the GERCOR prognostic index clinical and QoL factors: complete-case analysis | |||||
GERCOR (2 vs. 1) | 1.70 [1.14 – 2.54] | =0.0090 | NRI at 12 months = 0.35 [0.06; 0.44] | ||
GERCOR (3 vs. 1) | 3.35 [2.20 – 5.10] | <0.0001 | 0.67 [0.63 -0.71] *0.67 | 11.52 | NRI at 24 months = 0.27 [0.04; 0.38] |
NRI at 36 months = 0.28 [0.01; 0.45] | |||||
Mobility (2–3 vs. 1) | 1.77 [1.19 – 2.62] | =0.0047 | |||
Anxiety/depression (2–3 vs. 1) | 1.41 [1.03 – 1.92] | =0.0314 | |||
Improvement of the GERCOR prognostic index clinical and QoL factors: multiple imputation | |||||
GERCOR (2 vs. 1) | 1.77 [1.36 – 2.30] | <0.0001 | |||
GERCOR (3 vs. 1) | 2.49 [1.84 – 3.38] | <0.0001 | |||
ALP (>1ULN vs. ≤ 1ULN) | 1.25 [1.00 – 1.57] | =0.0480 | 0.67 [0.64 -0.71] | 9.56 [8.76 – 11.52] | |
Mobility (2–3 vs. 1) | 1.42 [1.08 – 1.86] | =0.0120 | R = 60% | ||
Pain/discomfort (2–3 vs. 1) | 1.55 [1.10 – 2.20] | =0.0140 | R = 138% |